Since 1999, the Vector Development Laboratory has developed and implemented novel cellular and gene-based treatments for a variety of diseases. Gene transfer vectors provide investigators important ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

In a first for this kind of research, Vector has shared the benchmarks, underlying code, and results in open-source to foster accountability, transparency, and collaboration that builds trust in AI.

First generation vectors may be suitable for applications where transient, high level activity is sufficient, and where immune responses to the vector or transgene are acceptable. Adenoviral vectors ...

and UCL’s world-leading research capabilities are supported by ViroCell’s delivery of a high quality, high yield lentiviral vector to advance UCL’s Phase I CARPALL (cohort 4) clinical trial ...

Vulnerability exploitation surged as the initial access vector for 20% of breaches—a 34% increase year over year and now ...